Work

ALK-targeted therapy in NSCLC: likely to be of benefit but not quite ready for prime time.

Year: 2011

Type: article

Source: PubMed

Author: Mark A Socinski

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2418587204

FWCI:

Cites:

Cited by:

Related to: 10